CIGB 2020

CIGB 2020 Uses, Dosage, Side Effects, Food Interaction and all others data.

CIGB 2020 is a vaccine candidate administered nasally and sublingually, working to strengthen immunity in the areas administered. The vaccine was developed and tested by the Center for Genetic Engineering and Biotechnology (CIGB), in Havana Cuba. As of July, 2020, a Randomized control clinical trial (RPCEC00000306) is underway to evaluate prophylaxis potential in suspected contacts of Covid-19 patients.

Trade Name CIGB 2020
Generic CIGB 2020 Vaccine
CIGB 2020 Vaccine Other Names CIGB 2020
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
CIGB 2020
CIGB 2020

Innovators Monograph

You find simplified version here CIGB 2020


*** Taking medicines without doctor's advice can cause long-term problems.
Share